RPG Investment Advisory LLC lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,906 shares of the exchange traded fund’s stock after selling 500 shares during the quarter. RPG Investment Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $1,802,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. Cranbrook Wealth Management LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at approximately $26,000. Gradient Investments LLC bought a new stake in SPDR S&P Biotech ETF during the first quarter worth approximately $27,000. Truewealth LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $29,000. Quattro Financial Advisors LLC boosted its holdings in SPDR S&P Biotech ETF by 49.6% during the fourth quarter. Quattro Financial Advisors LLC now owns 374 shares of the exchange traded fund’s stock worth $31,000 after buying an additional 124 shares in the last quarter. Finally, Lehman & Derafelo Financial Resources LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter worth approximately $32,000.
NYSEARCA:XBI traded down $0.80 during trading hours on Monday, reaching $89.10. 3,828,432 shares of the company’s stock were exchanged, compared to its average volume of 4,755,300. SPDR S&P Biotech ETF has a 12 month low of $64.38 and a 12 month high of $101.55.
ILLEGAL ACTIVITY NOTICE: “SPDR S&P Biotech ETF (XBI) Shares Sold by RPG Investment Advisory LLC” was first reported by Stock Observer and is the property of of Stock Observer. If you are reading this piece of content on another domain, it was stolen and reposted in violation of US & international trademark & copyright laws. The correct version of this piece of content can be viewed at https://www.thestockobserver.com/2019/04/15/spdr-sp-biotech-etf-xbi-shares-sold-by-rpg-investment-advisory-llc.html.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Recommended Story: Do closed-end mutual funds pay dividends?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.